Neutralizing antibody responses 10 months after mild and moderately-severe SARS-CoV-2 infection
Abstract
Improved understanding of immunity offered by the antibodies developed against SARS-CoV-2 is critical. Our study aimed at longitudinal analysis of presence and persistence of neutralizing antibodies over ten months in mild and moderately-severe COVID-19 recovered patients using two immunoassays.
Article Summary Line
Neutralizing IgG antibody persistency was demonstrated in 63.3% of the subjects (19 out of 30) at ten months post-infection with zero re-infections.
Related articles
Related articles are currently not available for this article.